SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

Lineage Cell Therapeutics Q1 EPS $(0.060) Misses $(0.050) Estimate

Lineage Cell Therapeutics (AMEX:LCTX) reported quarterly losses of $(0.060) per share which missed the analyst consensus estimate of $(0.050) by 20 percent. This is a 120 percent decrease over earnings of $0.300 per

Benzinga · 05/07/2020 20:18

Lineage Cell Therapeutics (AMEX:LCTX) reported quarterly losses of $(0.060) per share which missed the analyst consensus estimate of $(0.050) by 20 percent. This is a 120 percent decrease over earnings of $0.300 per share from the same period last year.